Search results for " Contrast media"

showing 6 items of 36 documents

Autoimmune pancreatitis: A challenging diagnostic puzzle for clinicians

2010

Autoimmune pancreatitis is a form of pancreatitis with autoimmune stigmata that may present as either focal or diffuse gland involvement. In focal forms, autoimmune pancreatitis shares demographic, clinical, biochemical and imaging features with pancreatic cancer. Since autoimmune pancreatitis is a benign disease and steroid therapy can rapidly resolve symptoms, improve radiological findings and avoid unnecessary surgery, the current clinical challenge is how to differentiate autoimmune pancreatitis from pancreatic neoplasia. Even though definitive diagnosis of the disease is difficult, several diagnostic criteria have been proposed and progress has been made in imaging studies. The managem…

medicine.medical_specialtyBiopsyAutoimmune Diseases; Biopsy; Cholangiopancreatography; Endoscopic Retrograde; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pancreatitis; Positron-Emission Tomography; Tomography; X-Ray ComputedUnnecessary SurgeryContrast MediaDiseaseGastroenterologyAutoimmune DiseasesEndoscopic RetrogradeFluorodeoxyglucose F18Internal medicinePancreatic cancerBiopsymedicineHumansIntensive care medicineTomographyAutoimmune pancreatitisCholangiopancreatography Endoscopic RetrogradeHepatologymedicine.diagnostic_testBenign diseasebusiness.industryGastroenterologymedicine.diseaseMagnetic Resonance ImagingCholangiopancreatographyX-Ray ComputedSteroid therapyPancreatitisPositron-Emission TomographyPancreatitisTomography X-Ray ComputedbusinessDigestive and Liver Disease
researchProduct

Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury.

2019

Abstract Background Nephrotoxic drug prescription may contribute to acute kidney injury (AKI) occurrence and worsening among critically ill patients and thus to associated morbidity and mortality. The objectives of this study were to describe nephrotoxic drug prescription in a large intensive-care unit cohort and, through a case–control study nested in the prospective cohort, to evaluate the link of nephrotoxic prescription burden with AKI. Results Six hundred and seventeen patients (62%) received at least one nephrotoxic drug, among which 303 (30%) received two or more. AKI was observed in 609 patients (61%). A total of 351 patients were considered as cases developing or worsening AKI a gi…

medicine.medical_specialtyIntensive-care units [MeSH]Critical Care and Intensive Care Medicine[SDV.MHEP.UN]Life Sciences [q-bio]/Human health and pathology/Urology and NephrologyMESH: Vancomycin03 medical and health sciences0302 clinical medicineMESH: Kidney tubular necrosisRenal insufficiency [MeSH]Internal medicineAnesthesiologyMESH: Renal insufficiencymedicineMESH: Intensive-care unitsKidney tubular necrosisMESH: Diuretics030212 general & internal medicineMedical prescriptionSimplified Acute Physiology ScoreProspective cohort studyMESH: Acutebusiness.industryResearchAcute kidney injurylcsh:Medical emergencies. Critical care. Intensive care. First aidMESH: Aminoglycosides030208 emergency & critical care medicineOdds ratiolcsh:RC86-88.9[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesmedicine.diseaseVancomycin [MeSH][SDV.MHEP.UN] Life Sciences [q-bio]/Human health and pathology/Urology and NephrologyDiuretics [MeSH]3. Good health[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesContrast media [MeSH]CohortMESH: Contrast mediaAminoglycosides [MeSH]businessAcute [MeSH]Kidney diseaseAnnals of intensive care
researchProduct

Contrast-enhanced ultrasound of hepatocellular carcinoma: where do we stand?

2019

Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in ultrasonography (US), and it is being increasingly used for the evaluation of focal liver lesions (FLLs). CEUS is unique in that it allows non-invasively assessment of liver perfusion in real time throughout the vascular phase, which has led to dramatic improvements in the diagnostic accuracy of US in the detection and characterization of FLLs, the choice of therapeutic procedures, and the evaluation of response. Currently, CEUS is included as a part of the suggested diagnostic work-up of FLLs, including in cirrhotic patients with hepatocellular carcinoma, resulting in better patient management and cost-effective d…

medicine.medical_specialtyLiver perfusionlcsh:Medical technologyHepatocellular carcinomaDiagnostic accuracyReview Article030218 nuclear medicine & medical imagingUltrasound contrast mediaLiver cirrhosi03 medical and health sciences0302 clinical medicinemedicineContrast-enhanced ultrasonographyRadiology Nuclear Medicine and imagingUltrasound contrast mediaUltrasonographybusiness.industryUltrasoundmedicine.diseasePatient managementlcsh:R855-855.5LiverHepatocellular carcinomaLiver cirrhosis030211 gastroenterology & hepatologyRadiologyUltrasonographybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaContrast-enhanced ultrasoundUltrasonography
researchProduct

SIUMB guidelines and recommendations for the correct use of ultrasound in the management of patients with focal liver disease

2019

The present document describes the SIUMB (Italian Society of Ultrasound in Medicine and Biology) guidelines for the use of ultrasound in the management of focal liver disease. The aim of the paper is to provide a clinical practice guideline for Italian physicians who are approaching the ultrasound study of a focal liver lesion. In particular, these guidelines provide simple indications, recommendations and general practice advices for the correct use of contrast-enhanced ultrasound (CEUS) in this scenario. They represent the SIUMB position of the ultrasound role in the diagnostic flow charts of the principal focal liver lesions, and are in agreement with other, previously published national…

medicine.medical_specialtySettore MED/09 - Medicina InternaHepatocellular carcinomaContrast enhanced ultrasoundCholangiocellular carcinoma; Contrast enhanced ultrasound; Focal nodular hyperplasia; Hemangioma; Hepatocellular carcinoma; MetastasisContrast MediaMetastasiCholangiocellular carcinoma030218 nuclear medicine & medical imagingMetastasis03 medical and health sciencesLiver disease0302 clinical medicineFocal nodular hyperplasiaInternal MedicineHumansMedicineRadiology Nuclear Medicine and imagingMedical physicsUltrasonographyUltrasound studybusiness.industryLiver NeoplasmsUltrasoundFocal nodular hyperplasiaGeneral MedicineGuidelinemedicine.diseaseClinical PracticeLiverLiver lesionOriginal Article030211 gastroenterology & hepatologyCholangiocellular carcinoma; Contrast enhanced ultrasound; Focal nodular hyperplasia; Hemangioma; Hepatocellular carcinoma; Metastasis; Contrast Media; Humans; Liver; Liver Neoplasms; UltrasonographybusinessHemangiomaContrast-enhanced ultrasound
researchProduct

Infarct characterization using CT

2017

Myocardial infarction (MI) is a major cause of death and disability worldwide. The incidence is not expected to diminish, despite better prevention, diagnosis and treatment, because of the ageing population in industrialized countries and unhealthy lifestyles in developing countries. Nowadays it is highly requested an imaging tool able to evaluate MI and viability. Technology improvements determined an expansion of clinical indications from coronary plaque evaluation to functional applications (perfusion, ischemia and viability after MI) integrating additional phases and information in the mainstream examination. Cardiac computed tomography (CCT) and cardiac MR (CMR) employ different contra…

medicine.medical_specialtycoronary arterieIschemiaReview Article030204 cardiovascular system & hematologyPharmacological stress030218 nuclear medicine & medical imagingIodinated contrast media03 medical and health sciences0302 clinical medicineImaging Toolcardiovascular diseasemedicineMyocardial infarctionmyocardial infarction (MI)Cause of deathbusiness.industrycomputed tomographymedicine.diseaseCoronary arteriesmedicine.anatomical_structureAtherosclerosiRadiologyCardiology and Cardiovascular MedicinebusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaPerfusionCardiovascular Diagnosis and Therapy
researchProduct

Intravenous Contrast Material for Cardiac Computed Tomography

2023

Purpose: The Italian Registry of Contrast Material use in Cardiac Computed Tomography (iRCM-CCT) is a multicenter, multivendor, observational study on the use of contrast media (CM) in patients undergoing cardiac computed tomography (CCT). The aim of iRCM-CCT is to assess image quality and safety profile of intravenous CM compounds. Materials and methods: iRCM-CCT enrolled 1842 consecutive patients undergoing CCT (≥50 per site) at 20 cluster sites with the indication of suspected coronary artery disease. Demographic characteristics, CCT, and CM protocols, clinical indications, safety markers, radiation dose reports, qualitative (ie, poor vascular enhancement) and quantitative (ie, HU attenu…

safetyPulmonary and Respiratory MedicineSettore MED/36 - Diagnostica per Immagini e Radioterapiacoronary arteriecomputed tomography angiography; contrast media; coronary arteries; image enhancement; safetyRadiology Nuclear Medicine and imagingcomputed tomography angiography; contrast media; coronary arteries; image enhancement; safety;image enhancementcontrast mediacomputed tomography angiographycoronary arteriesimage enhancement contrast media safetycomputed tomography angiographycoronary arteriesimage enhancementcontrast mediasafetyJournal of Thoracic Imaging
researchProduct